Decreasing ED Utilization by Nudging Patients to Call Their Providers

July 14, 2023 updated by: Amir Goren, Geisinger Clinic

Decreasing ED Utilization by Nudging Patients to Call Their Provider or Triage Nurse After Women's Health Procedures

In the present study, patients will be sent a message shortly after completing a medical procedure that informs or reminds them that they can reach out to Geisinger, and how to do it, if they have any medical issues or concerns. Researchers will assess if such messages make patients more likely to contact Geisinger with post-procedure medical concerns and decrease emergency department utilization.

Study Overview

Detailed Description

Decreasing emergency department (ED) over-utilization is a priority for healthcare systems across the country. Patients uncertain about a medical issue routinely end up in the ED when less costly and time-consuming alternatives could have addressed their concern. If patients reach out to healthcare facilities rather than heading directly to the ED, they can often be directed toward resources better suited to their concerns than the ED.

Geisinger is thus working to encourage patients to contact healthcare providers if any concerns arise and patients are uncertain about where to go for care. Patients who have recently had a medical procedure may be particularly valuable to encourage, as they routinely have concerns related to the procedure and discharge can serve as a useful touch-point to remind the patient where they can go for questions or concerns.

In the present study, patients will be sent a patient portal message shortly after completing any Women's Health medical procedure. The message will inform or remind patients how they can reach Geisinger if they have any medical issues or concerns. The purpose of this study is to assess if such messages make patients more likely to contact Geisinger with medical concerns and, in turn, decrease unnecessary ED utilization. This study will A/B test 2 messages, encouraging patients to either call their recent provider directly or to call a tele-nurse hotline, and will assess if these messages perform better than a control group that will not be sent any such message.

Generalized linear models will examine the primary study outcomes as a function of the study arms (between-subjects).

Study Type

Interventional

Enrollment (Actual)

11546

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Danville, Pennsylvania, United States, 17822
        • Geisinger

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient had a procedure in Women's Health within the study period (including both surgical and in-office procedures as well as baby delivery)
  • Patient is enrolled in myGeisinger, Geisinger's patient portal

Exclusion Criteria:

  • If procedure was labor that resulted in fetal demise or stillborn.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention control group
Experimental: Nudge: call provider
This group will receive a patient portal message the morning after completing their procedure. The message will encourage patients to call their recent Women's Health provider (with appropriate phone number listed) if any questions or concerns arise about their healthcare.
patient portal message
nudging calling the patient's provider
Experimental: Nudge: call tele-nurse
This group will receive a patient portal message the morning after completing their procedure. The message will encourage patients to call Geisinger's nurse triage hotline (with appropriate phone number listed) if any questions or concerns arise about their healthcare.
patient portal message
nudging calling the tele-nurse

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phone calls
Time Frame: 18 months or as long as it takes to reach N=17,300, whichever occurs first
Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment
18 months or as long as it takes to reach N=17,300, whichever occurs first
ED utilization
Time Frame: 18 months or as long as it takes to reach N=17,300, whichever occurs first
Proportion of patients who visit the ED within 30 days of their appointment
18 months or as long as it takes to reach N=17,300, whichever occurs first

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phone calls
Time Frame: 12 months
Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment
12 months
ED utilization
Time Frame: 12 months
Proportion of patients who visit the ED within 30 days of their appointment
12 months
Phone calls - surgical patients only
Time Frame: 18 months or as long as it takes to reach N=17,300, whichever occurs first
Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment
18 months or as long as it takes to reach N=17,300, whichever occurs first
ED utilization - surgical patients only
Time Frame: 18 months or as long as it takes to reach N=17,300, whichever occurs first
Proportion of patients who visit the ED within 30 days of their appointment
18 months or as long as it takes to reach N=17,300, whichever occurs first
Phone calls - surgical patients only
Time Frame: 12 months
Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment
12 months
ED utilization - surgical patients only
Time Frame: 12 months
Proportion of patients who visit the ED within 30 days of their appointment
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amir Goren, PhD, Geisinger Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 16, 2021

Primary Completion (Actual)

June 15, 2023

Study Completion (Actual)

June 15, 2023

Study Registration Dates

First Submitted

September 23, 2020

First Submitted That Met QC Criteria

September 23, 2020

First Posted (Actual)

September 29, 2020

Study Record Updates

Last Update Posted (Actual)

July 18, 2023

Last Update Submitted That Met QC Criteria

July 14, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020-0849

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency.

IPD Sharing Time Frame

The data will become available after publication of study results in a scientific journal and will be available as long as the Open Science Framework hosts the data.

IPD Sharing Access Criteria

The data on the Open Science Framework will be open to anyone requesting that information.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergency Treatment

Clinical Trials on message

Subscribe